|Articles|September 22, 2022
COVID-19 Agent Molnupiravir
Author(s)YMC Europe GmbH
Molnupiravir, which is a prodrug, and its active agent β-d-N4-hydroxycytidine can be separated by using a YMC-Triart C18 UHPLC column and a MS-compatible mobile phase.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
HPLC 2025 Revisited: A Year-End Review of LCGC's Conference Coverage Highlights (Part One)
2
A Novel Machine Learning Method for Predicting Retention Time of Small Molecule Pharmaceutical Compounds Across Reversed-phase HPLC Columns
3
Dr. Rigoberto Advincula on Advancing Polymer Research With Py-GC/MS
4
Best of the Week: Career Opportunities for PhD Graduates, Human Expertise and Machine Learning
5